Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
Energesis Pharmaceuticals is developing therapeutics for diabetes, obesity, and lipid disorders by targeting brown adipose tissue (BAT). The Company’s approach is a novel strategy leveraging recent scientific insights in BAT biology to increase the body’s ability to burn stored fat and lower insulin resistance.